{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:20:03Z","timestamp":1785284403858,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020098","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["800176"],"award-info":[{"award-number":["800176"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016302","name":"Coalition for Epidemic Preparedness Innovations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016302","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.vaccine.2023.11.030","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T04:03:01Z","timestamp":1700625781000},"page":"7587-7597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Conducting an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned"],"prefix":"10.1016","volume":"41","author":[{"given":"Ynke","family":"Larivi\u00e8re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tr\u00e9sor Zola","family":"Matuvanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwen","family":"Lemey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard Isekah","family":"Osang'ir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Peter","family":"Vermeiren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solange","family":"Milolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Meta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2928-8522","authenticated-orcid":false,"given":"Primo","family":"Kimbulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Esanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junior","family":"Matangila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Van geertruyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Van Damme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivi","family":"Maketa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hypolite","family":"Muhindo-Mavoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Mitashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2023.11.030_b0005","doi-asserted-by":"crossref","first-page":"e1001228","DOI":"10.1371\/journal.pmed.1001228","article-title":"Clinical trials have gone global: is this a good thing?","volume":"9","author":"Lang","year":"2012","journal-title":"PLoS Med"},{"issue":"9","key":"10.1016\/j.vaccine.2023.11.030_b0010","doi-asserted-by":"crossref","first-page":"e046835","DOI":"10.1136\/bmjopen-2020-046835","volume":"11","author":"Larivi\u00e8re","year":"2021","journal-title":"BMJ Open"},{"issue":"22","key":"10.1016\/j.vaccine.2023.11.030_b0015","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1411099","article-title":"Ebola virus disease in the Democratic Republic of Congo","volume":"371","author":"Maganga","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.11.030_b0020","doi-asserted-by":"crossref","unstructured":"Rosello A, et al. Ebola virus disease in the Democratic Republic of the Congo, 1976-201. Elife 2015; 4.","DOI":"10.7554\/eLife.09015"},{"issue":"49","key":"10.1016\/j.vaccine.2023.11.030_b0025","first-page":"1168","article-title":"Ebola virus disease in health care workers\u2013Sierra Leone, 2014","volume":"63","author":"Kilmarx","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2023.11.030_b0030","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/infdis\/jiaa747","article-title":"Risk factors for Ebola exposure in health care workers in Boende, Tshuapa Province, Democratic Republic of the Congo","volume":"226","author":"Doshi","year":"2022","journal-title":"J Infect Dis"},{"issue":"19","key":"10.1016\/j.vaccine.2023.11.030_b0035","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/jnci\/dji354","article-title":"Approaches vary for clinical trials in developing countries","volume":"97","author":"Hayasaka","year":"2005","journal-title":"JNCI: J Natl Cancer Instit"},{"issue":"5(Suppl 5)","key":"10.1016\/j.vaccine.2023.11.030_b0040","doi-asserted-by":"crossref","first-page":"S422","DOI":"10.1093\/cid\/civ598","article-title":"Ethical Challenges and Lessons Learned During the Clinical Development of a Group A Meningococcal Conjugate Vaccine","volume":"61 Suppl","author":"Martellet","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2023.11.030_b0045","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1745-6215-12-145","article-title":"The challenges and opportunities of conducting a clinical trial in a low resource setting: the case of the Cameroon mobile phone SMS (CAMPS) trial, an investigator initiated trial","volume":"12","author":"Mbuagbaw","year":"2011","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.vaccine.2023.11.030_b0050","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1186\/s13063-020-04620-8","article-title":"Conducting clinical trials in sub-Saharan Africa: challenges and lessons learned from the Malawi Cryptosporidium study","volume":"21","author":"Toto","year":"2020","journal-title":"Trials"},{"issue":"25","key":"10.1016\/j.vaccine.2023.11.030_b0055","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1016\/j.vaccine.2022.04.094","article-title":"Setting-up an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned","volume":"40","author":"Zola Matuvanga","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.11.030_b0060","unstructured":"RDC, M.d.l.S.d.l. Lignes directrices de l'\u00e9valuation \u00e9thique de la recherche impliquant des sujets humains en R\u00e9publique D\u00e9mocratique du Congo 2006 [cited 2023 16 June 2023]; Available from: https:\/\/clinregs.niaid.nih.gov\/sites\/default\/files\/documents\/DRC\/G-EthicalEval.pdf."},{"issue":"1","key":"10.1016\/j.vaccine.2023.11.030_b0065","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1371\/journal.pmed.0040003","article-title":"The structure and function of research ethics committees in Africa: a case study","volume":"4","author":"Kass","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2023.11.030_b0070","unstructured":"Council for International Organizations of Medical Sciences (CIOMS). International ethical guidelines for health-related research involving humans 2016. Available from: https:\/\/cioms.ch\/wp- content\/uploads\/2017\/01\/WEB-CIOMS-EthicalGuidelines.pdf."},{"issue":"7454","key":"10.1016\/j.vaccine.2023.11.030_b0075","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1136\/bmj.328.7454.1494","article-title":"Medical researchers' ancillary clinical care responsibilities","volume":"328","author":"Belsky","year":"2004","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.vaccine.2023.11.030_b0080","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-005726","article-title":"Algorithm for the support of non-related (serious) adverse events in an Ebola vaccine trial in the Democratic Republic of the Congo","volume":"6","author":"Lemey","year":"2021","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.vaccine.2023.11.030_b0085","unstructured":"Lemey G, et al. Researchers\u2019 responsibilities in resource-constrained settings: experiences of implementing an ancillary care policy in a vaccine trial in the Democratic Republic of the Congo. Research Ethics 0(0): p. 17470161231194139."},{"key":"10.1016\/j.vaccine.2023.11.030_b0090","unstructured":"Innovative health Initiative. We are an EU public-private partnership funding health research and innovation. 13 February 2023]; Available from: https:\/\/www.ihi.europa.eu\/."},{"key":"10.1016\/j.vaccine.2023.11.030_b0095","unstructured":"EUR-Lex. Regulation (EU) No 536\/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001\/20\/EC Text with EEA relevance; 2022: https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=celex%3A32014R0536."},{"key":"10.1016\/j.vaccine.2023.11.030_b0100","unstructured":"European Medicines Agency. Guideline for good clinical practice E6(R2). In: EMA\/CHMP\/ICH\/135\/1995, European Medicines Agency, Editor; 2016: https:\/\/www.ema.europa.eu\/en\/ich-e6-r2-good-clinical-practice-scientific-guideline."},{"issue":"6","key":"10.1016\/j.vaccine.2023.11.030_b0105","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jen.2012.05.012","article-title":"Emergency nursing resource: non-invasive temperature measurement in the emergency department","volume":"38","author":"Barnason","year":"2012","journal-title":"J Emerg Nurs"},{"key":"10.1016\/j.vaccine.2023.11.030_b0110","unstructured":"World Health Organization. Interagency Emergency Health Kit 2017; 2017; Available from: https:\/\/www.who.int\/emergencies\/emergency-health-kits\/interagency-emergency-health-kit-2017."},{"key":"10.1016\/j.vaccine.2023.11.030_b0115","unstructured":"World health Organization. Model List of Essential Medicines; 2021; Available from: file:\/\/\/C:\/Users\/YLariviere\/Downloads\/WHO-MHP-HPS-EML-2021.02-eng-1.pdf."},{"issue":"8","key":"10.1016\/j.vaccine.2023.11.030_b0120","doi-asserted-by":"crossref","first-page":"e28573","DOI":"10.2196\/28573","article-title":"Use of Iris scanning for biometric recognition of healthy adults participating in an Ebola vaccine trial in the Democratic Republic of the Congo: Mixed Methods Study","volume":"23","author":"Zola Matuvanga","year":"2021","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.vaccine.2023.11.030_b0125","article-title":"The republic of Congo's infrastructure: a continental perspective","author":"Pushak","year":"2011","journal-title":"World Bank Policy Res Working Paper"},{"issue":"6","key":"10.1016\/j.vaccine.2023.11.030_b0130","doi-asserted-by":"crossref","first-page":"2127272","DOI":"10.1080\/21645515.2022.2127272","article-title":"Challenges to COVID-19 vaccine introduction in the Democratic Republic of the Congo - a commentary","volume":"18","author":"Zola Matuvanga","year":"2022","journal-title":"Hum Vaccin Immunother"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23013634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23013634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:32:31Z","timestamp":1759404751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23013634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":26,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0264410X23013634"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.11.030","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conducting an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.11.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}